Table 2. Analysis of canine leishmaniasis in owned dogs living within 300 m from 82 human cases, local health unit of Bologna, northern Italy, 2011–2022 (n = 1,422).
Year of diagnosis | Human cases considered | Dogs sampleda | Per cent positive | 95% CI | ||
---|---|---|---|---|---|---|
Total | Negativeb | Positivec | ||||
2011 | 0 | 0 | 0 | 0 | 0 | 0–100 |
2012 | 1 | 28 | 28 | 0 | 0 | 0–12.34 |
2013 | 13 | 489 | 481 | 8 | 1.64 | 0.71–3.20 |
2014 | 8 | 133 | 131 | 2 | 1.50 | 0.18–5.33 |
2015 | 5 | 112 | 111 | 1 | 0.89 | 0.02–4.87 |
2016 | 4 | 114 | 113 | 1 | 0.88 | 0.02–4.79 |
2017 | 6 | 61 | 59 | 2 | 3.28 | 0.40–11.35 |
2018 | 17 | 135 | 132 | 3 | 2.22 | 0.46–6.36 |
2019 | 13 | 255 | 249 | 6 | 2.35 | 0.87–5.05 |
2020 | 1 | 7 | 7 | 0 | 0 | 0–40.96 |
2021 | 7 | 41 | 40 | 1 | 2.44 | 0.06–12.86 |
2022 | 7 | 47 | 47 | 0 | 0 | 0–7.55 |
Total | 82 | 1,422 | 1,398 | 24 | 1.69 | 1.08–2.50 |
CI: confidence interval.
a Owned dogs living within 300 m from the identified human cases.
b Dogs that tested negative with an indirect immunofluorescence test (IF) (titre < 1:160).
c Dogs that tested positive with an IF (titre ≥ 1:160).